Explore more publications!
Florida Health Daily
Got News to Share?

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on December 10, 2025

Juvenile Welfare Board of Pinellas County Announces Major Investment to Keep Children Safe Online
Dec. 10, 2025

Juvenile Welfare Board of Pinellas County Announces Major Investment to Keep Children Safe Online

Indeterminate EIN Presswire
Bionews Releases Inaugural Rare Trust in AI Index, Finds Low Confidence in AI Among Rare Disease Patients
Dec. 10, 2025

Bionews Releases Inaugural Rare Trust in AI Index, Finds Low Confidence in AI Among Rare Disease Patients

Indeterminate EIN Presswire
Comfort Keepers of Polk County Shares Update on 24-Hour Home Care Availability for Seniors in Winter Haven, FL
Dec. 10, 2025

Comfort Keepers of Polk County Shares Update on 24-Hour Home Care Availability for Seniors in Winter Haven, FL

Indeterminate EIN Presswire
BenaVest Helps Americans Navigate 2026 ACA and Health Plan Premium Increases
Dec. 10, 2025

BenaVest Helps Americans Navigate 2026 ACA and Health Plan Premium Increases

Indeterminate EIN Presswire
Mellow Fellow and Arvida Labs Respond to Federal Hemp THC Ban and Ongoing Marijuana Rescheduling Review
Dec. 10, 2025

Mellow Fellow and Arvida Labs Respond to Federal Hemp THC Ban and Ongoing Marijuana Rescheduling Review

Indeterminate EIN Presswire
KYRYS Medical Launches Sterile, Single-Use Instrumentation for the SiJoin® T5 System to Boost SI Fusion Efficiency
Dec. 10, 2025

KYRYS Medical Launches Sterile, Single-Use Instrumentation for the SiJoin® T5 System to Boost SI Fusion Efficiency

Indeterminate EIN Presswire
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Dec. 10, 2025

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Dec. 10, 2025

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Breezy Med and Lovell Partner to Expand Access to Automated aHP Bio-Decontamination in Federal Healthcare
Dec. 10, 2025

Breezy Med and Lovell Partner to Expand Access to Automated aHP Bio-Decontamination in Federal Healthcare

Indeterminate EIN Presswire
Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec. 10, 2025

Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
Dec. 10, 2025

Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program

Indeterminate GlobeNewswire
Clearmind Medicine Announces 1-for-40 Reverse Share Split
Dec. 10, 2025

Clearmind Medicine Announces 1-for-40 Reverse Share Split

Indeterminate GlobeNewswire
DLH Reports Fiscal 2025 Fourth Quarter Results
Dec. 10, 2025

DLH Reports Fiscal 2025 Fourth Quarter Results

Indeterminate GlobeNewswire
Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
Dec. 10, 2025

Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome

Indeterminate GlobeNewswire
Corbus Pharmaceuticals to Report Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity on Thursday, December 11, 2025
Dec. 10, 2025

Corbus Pharmaceuticals to Report Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity on Thursday, December 11, 2025

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome
Dec. 10, 2025

Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome

Indeterminate GlobeNewswire
Alameda Health System wins equity award for breast cancer screening campaign
Dec. 10, 2025

Alameda Health System wins equity award for breast cancer screening campaign

Indeterminate GlobeNewswire
Allsup Helps Individuals With Crohn’s Disease And Ulcerative Colitis Overcome Barriers To SSDI Benefits
Dec. 10, 2025

Allsup Helps Individuals With Crohn’s Disease And Ulcerative Colitis Overcome Barriers To SSDI Benefits

Indeterminate GlobeNewswire
Vietnam Vet cares for wife and wartime nurse
Dec. 10, 2025

Vietnam Vet cares for wife and wartime nurse

Indeterminate GlobeNewswire
Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with Fulvestrant in Patients with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer
Dec. 10, 2025

Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with Fulvestrant in Patients with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions